C1q deficiency is the strongest known risk factor for SLE (systemic lupus erythematosus) but its endogenous cellular origin remains limitedly understood. In the present study we investigate the production of C1q by both cultured and endogenous bone osteoclasts. Blood monocytes were cultured with RANKL (receptor activator of nuclear factor κB ligand) and M-CSF (macrophage colony-stimulating factor) to generate osteoclasts and these cells expressed C1Q mRNA and also secreted C1q protein. Intracellular C1q was detectable in developing osteoclasts at day 3 by Western blotting and was also detectable by flow cytometry. By immunofluorescence microscopy, C1q was preferentially detected in immature osteoclasts. By multiple detection methods, C1q expression was markedly increased after IFNγ (interferon γ ) treatment. By immunohistochemistry, C1q was also detected in endogenous bone osteoclasts. When osteoclasts were cultured on immobilized C1q, these cells exhibited 2-7-fold increases in the expression of signature osteoclast genes [TRAP (tartrate-resistant acid phosphatase), cathepsin K, calcitonin receptor, carbonic anhydrase II and NFATc1 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1)], suggesting an osteoclastogenic capability. This is the first report of C1q production by osteoclasts. Its ability to enhance osteoclast development implies reduced osteoclastogenesis in patients with SLE as they often experience decreased C1q levels. This is consistent with the non-erosive nature of lupus arthritis.
INTRODUCTION
C1q is an abundant plasma complement protein, which forms the C1 complex with the tetrameric C1r 2 C1s 2 serine proteases [1, 2] . In microbial infections, C1q recognizes antibody-reacted pathogens and causes complement activation through the classical pathway [1, 2] . In addition, complement activation is also triggered through the C1q-independent lectin and alternative pathways, with all three pathways converging at C3 activation and ultimately leading to the formation of membrane lytic C8-C9 complexes, the generation of anaphylatoxins (C3a and C5a), and the opsonization of pathogens by C3b and iC3b to enhance phagocytosis [1] [2] [3] .
In steady state, late-apoptotic and necrotic cells are likely to be the major C1q targets. C1q binds to membrane blebs on apoptotic cells and, at the molecular level, C1q recognizes surface-exposed calreticulin which is otherwise an ER (endoplasmic reticulum)-resident protein in live cells [4, 5] . Alternatively, apoptotic cells absorb polyclonal IgM on the surface, which then recruits C1q [6] [7] [8] . Binding of C1q to apoptotic cells, which are the sources of self-antigens or autoantigens, enhances phagocytosis [5] [6] [7] [8] [9] . This helps in autoantigen clearance and is relevant to the fact that, while genetic C1q deficiency increases susceptibility to infections, the main clinical manifestation is SLE (systemic lupus erythematosus) [10] [11] [12] [13] .
The current efforts in understanding the causative relationship between C1q deficiency and SLE pathogenesis have not embraced the intriguing mode of C1q biosynthesis. Being one of over 20 complement proteins in the plasma, it is, however, distinct from the hepatic origin of these proteins and is selectively produced by macrophages and DCs (dendritic cells) [14] [15] [16] [17] . These are APCs (antigen-presenting cells) populating different organs as key scavengers and playing critical roles in the induction and maintenance of tolerance [18] [19] [20] .
Endogenous macrophages exhibit striking organ-specific heterogeneity [18] , raising the question whether C1q production is a common property of these cells. C1q expression by macrophages in the liver (Kupffer cells) and brain (microglia) has been indicated and, more recently, C1q has been demonstrated to bind to apoptotic neurons and enhance their phagocytosis by microglia [21] [22] [23] . However, C1q production by osteoclasts has not been previously investigated. In the present paper we report C1q production by cultured and endogenous osteoclasts, and demonstrate that C1q strongly promotes osteoclast development from monocytes.
EXPERIMENTAL

Reagents
The following antibodies were used in the present study: mouse anti-C1q (AbD Serotec), goat anti-C1q (Sigma-Aldrich), rabbit anti-EEA1 (early endosome antigen 1) (Santa Cruz Biotechnology), goat anti-rabbit IgG [Cy3 (indocarbocyanine)-conjugated] (Jackson ImmunoResearch Laboratories), rabbit anti-goat IgG (alkaline phosphatase-conjugated) (Bio-Rad Laboratories) and goat anti-mouse IgG (horseradish peroxidaseconjugated) (Dako). M-CSF (macrophage colony-stimulating factor), GM-CSF (granulocyte/M-CSF) and IL (interleukin)-4
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were obtained from R&D Systems. RANKL [RANK (receptor activator of nuclear factor κB) ligand] and IFNγ (interferon γ ) were purchased from Peprotech. LPS (lipopolysaccharide) was obtained from Sigma-Aldrich and rhodamine-phalloidin was from Invitrogen. Purified plasma C1q was purchased from Sigma-Aldrich and then passed through a PD-10 desalting column, equilibrated with endotoxin-free PBS, for buffer exchange. Purity was judged by SDS/PAGE and silver staining. At 50 μg/ml, the eluted C1q showed no induction of TNFα (tumour necrosis factor α) from macrophages at 5×10 5 /ml (100 μl/well in 96-well plates) whereas, as a positive control, LPS at 1 ng/ml induces significant TNFα production (3-4 ng/ml; results not shown).
Culturing of osteoclasts
Monocytes were isolated from buffy coat as described previously [24] . Buffy coat was obtained from anonymous and apparently healthy adult blood donors recruited by the National University Hospital, Singapore with approval by the Institutional Ethics Committee. In each set of osteoclast, macrophage and DC cultures, buffy coat from one blood donor was used. Cells were re-suspended in αMEM (α-minimal essential medium; Invitrogen) supplemented with 10 % (v/v) heatinactivated HyClone FBS (fetal bovine serum), 100 units/ml penicillin, 100 μg/ml streptomycin, M-CSF (20 ng/ml) and RANKL (40 ng/ml) (0.5×10 6 cells/ml) and cultured in a six-well plate (2 ml/well) for up to 21 days at 37
• C in the presence of 5 % CO 2 . In regular cultures, half of the medium was replaced by fresh medium every 3 days. Macrophages and DCs were cultured from these monocytes, as described previously [24] , in RPMI 1640 medium. Macrophages were generated from these cells in the presence of M-CSF (20 ng/ml) and DCs were cultured using GM-CSF and IL-4 (each at 20 ng/ml).
TRAP (tartrate-resistant acid phosphatase) staining
TRAP staining was performed using the acid phosphatase/leucocytes (TRAP) kit (Sigma-Aldrich). Briefly, cells were fixed with a citrate/acetone/formaldehyde solution for 30 s and then washed extensively with water. After incubation for 1 h at 37
• C with the acetone/naphthol AS-BI phosphoric acidtartrate staining solution in the dark, the plates were washed with water, air-dried and examined using the Olympus IX81 inverted microscope and the ImagePro Plus software (Olympus).
Flow cytometry
Osteoclasts, macrophages and DCs were fixed and permeabilized using the cytofix/cytoperm fixation/permeabilization solutions kit (BD Biosciences) and stained for 30 min at 4
• C with a mouse anti-C1q antibody (1 μg/ml). After washing, cells were further stained for 30 min with goat anti-mouse IgG [PE (phycoerythrin)-conjugated]. Cells were washed twice in PBS containing 2 % (v/v) BCS (bovine calf serum) and fixed in 1 % (w/v) paraformaldehyde in PBS (pH 7.6). The cells were analysed using the CyAn flow cytometer and Summit software (Beckman Coulter).
Fluorescence microscopy
Osteoclasts were cultured on glass coverslips and were, after washing in PBS, fixed for 20 min in 4 % (w/v) paraformaldehyde. Cells were permeabilized for 30 min with 0.1 % saponin in PBS and were, after washing, incubated for 1 h with mouse anti-C1q and rabbit anti-EEA1 antibodies (each at 1 μg/ml). Cells were washed and incubated for 1 h with goat antirabbit (Cy3-conjugated) and goat anti-mouse (FITC-conjugated) IgG. The coverslips were washed and mounted using the fluorescent Vectorshield mounting medium, containing DAPI (4 ,6-diamidino-2-phenylindole, 1.5 μg/ml; Vector Laboratories). Cells were analysed using a Leica TCS SP5 confocal microscope.
These permeabilized cells were also stained with rhodaminephalloidin (5 units/ml) for 30 min. After washing, the coverslips were mounted using the DAPI-containing Vectorshield medium. These cells were analysed using an Olympus BX-60 digital microscope and ImagePro Plus software (Olympus).
Bone resorption assay
Monocytes were cultured on BioCoat osteologic discs (BD Biosciences) to generate osteoclasts. At day 8, cells were removed by washing with bleach and the slides were thoroughly rinsed with water. As a control, macrophages were also cultured on these discs. Resorption pits were visualized using an Olympus IX81 inverted microscope and ImagePro Plus software (Olympus).
PCR
RNA was isolated from cultured osteoclasts, macrophages and DCs using the Nucleospin RNA II kit (Invitrogen) and cDNA was synthesized with the Advantage RT-for-PCR Kit (Clontech Laboratories). qPCR (quantitative real-time PCR) was performed in a 20 μl volume using the SYBR Green PCR master mix and the ABI 7500 real-time PCR machine (Applied Biosystems). Primers used were: cathepsin K (5 -ATAACAACAAGGTGGATGAAA-3 /5 -TGGGATATAAAGGGTGTCAT-3 ), calcitonin receptor Conventional PCR was performed with C1qA (5 -CTTCC-TCATCTTCCCATCT-3 /5 -GTTCAGCAGACACAGACA-3 ), C1qB (5 -AGGCGTCTGACACAGTATG-3 /5 -CCTGGAAGC-CCTTTCTCT-3 ), C1qC (5 -ACCTGCAGTTCCTTCTCC-3 /5 -TTCTCCCTTCTGCCCTTT-3 ), cathepsin K and GAPDH primers for 30 cycles each at 94
• C for 30 s, 58
• C for 30 s and 72
• C for 30 s. The reactions were examined on 1.5 % (w/v) agarose gels.
ELISA for C1q
Maxisorp plates (Nunc) were coated overnight at 4
• C with goat anti-human C1q (IgG, 0.5 μg/ml in PBS). The plates were washed in PBS-T (PBS containing 0.05 % Tween 20) and blocked for 2 h with PBS-BSA [PBS containing 3 % (v/v) BSA]. The plates were incubated overnight at 4
• C with medium from osteoclast, macrophage or DC cultures in triplicate wells or, as controls, incubated with purified C1q as standards. After washing, the plates were incubated for 2 h with a mouse anti-C1q antibody (0.4 μg/ml). The plates were washed and incubated for 1 h with a goat anti-mouse IgG antibody (horseradish peroxidaseconjugated). OptEIA TMB substrate (BD Biosciences) was then added. The reactions were stopped by the addition of 1 M sulfuric acid (50 μl/well) and the plates were read at 450 nm using a BioRad Model 680 microplate reader.
Western blotting
Osteoclasts, macrophages and DCs were washed and lysed on ice in a cell extraction buffer (Biosource) supplemented with a protease inhibitor cocktail (Sigma-Aldrich). Proteins were separated by SDS/PAGE (12.5 % gels) and C1q and β-actin were detected by Western blotting. Briefly, the blots were blocked for 1 h in TBS [Tris-buffered saline: 50 mM Tris and 150 mM NaCl (pH 7.4)] containing 0.1 % Tween 20, 0.05 % sodium azide and 5 % (w/v) non-fat dried skimmed milk powder and then incubated with goat anti-C1q or mouse anti-β-actin antibodies (1 μg/ml) overnight at 4
• C. The blots were washed and then incubated for 2 h with rabbit anti-goat or goat anti-mouse IgG (alkaline phosphatase-conjugated). Signals were developed using the Immuno-Star AP substrate (Bio-Rad Laboratories).
Immunohistochemistry
Tissue specimens of femoral bone were obtained at the Department of Pathological Anatomy, 1st Medical Institute, Leningrad/St Petersburg, Russia. The study was carried out in accordance with the principles outlined in the Helsinki Declaration of 1975, as revised in 1983. Tissue specimens were fixed in 10 % neutral-buffered formalin solution and were decalcified for 5 h using Decalcifying Solution-Lite (SigmaAldrich) prior to further processing and embedding into paraffin blocks. These blocks were cross-cut into 3 μm tissue sections. For single immunostaining, after elimination of endogenous peroxidase activity by 3 % H 2 O 2 , sections were pre-incubated with normal non-immune serum and then tested by ABC (avidinbiotin complex) using a standard ABC immunoperoxidase method as described previously [15, 25] . C1q was identified using a goat anti-C1q antibody (Sigma-Aldrich, catalogue number C3900; 1:100 dilution). After washing in TPBS (Tris-PBS), pH 7.6, the sections were incubated with a biotin-labelled secondary antibody, followed by a treatment with ABC. After washing in TPBS, brown staining was produced by 5 min treatment with DAB (diaminobenzidine). All of the incubations were completed at room temperature (22 • C). For negative controls, a non-immune goat IgG was used in place of the anti-C1q antibody. None of the negative control sections showed positive immune staining. Counterstaining was performed with Mayer's haematoxylin.
Statistical analysis
A multiple unpaired t test was performed for the ELISA experiments (*P < 0.05, **P < 0.01). For the qPCR experiment, one-way ANOVA was performed with Bonferroni's test (*P < 0.05, **P < 0.01, ***P < 0.001).
RESULTS
Morphological features of cultured osteoclasts
Microscopic examination of the cultured osteoclasts showed that these cells were generally much larger than macrophages ( Figures 1A and 1B) . Furthermore, cultured osteoclasts were heterogeneous in size, whereas the macrophages were largely uniform ( Figures 1A and 1B) . Secondly, most of these cultured osteoclasts exhibited intense TRAP expression, but this was absent in the majority of cultured macrophages ( Figures 1A and  1B) . Staining with DAPI showed that the majority of osteoclasts were multinucleated, with some large osteoclasts having up to ten nuclei ( Figure 1C) . Mononuclear osteoclasts are a minor population in the osteoclast culture. This type of osteoclast heterogeneity was also observed in earlier cultures [26, 27] . In contrast, macrophages were typically mononuclear ( Figure 1D ).
Endogenous bone osteoclasts develop characteristic F-actin (filamentous actin) rings which form the sealing zone in vivo between the ruffled osteoclast membranes and bone surfaces [28] . With rhodamine-phalloidin staining, F-actin rings were observed in all osteoclasts in culture ( Figure 1C ). However, these were absent in macrophages ( Figure 1D ).
We then examined these osteoclasts in bone resorption, which is the major function of endogenous bone osteoclasts. Osteoclasts were therefore cultured on osteologic discs and resorption pits were detected after removing the cells. As shown in Figure 1 (E), characteristic resorption pits were generated by small as well as large osteoclasts, but these were not detected in the macrophage culture ( Figure 1F ). This is consistent with the strong TRAP expression in cultured osteoclasts ( Figure 1C ), a phosphatase which degrades skeletal phosphoproteins [29] . These morphological data collectively suggest that the cultured cells have acquired the characteristics of osteoclasts.
Osteoclasts express C1Q mRNA
C1q production by these cultured osteoclasts was first examined at the mRNA level. C1q is a large and secreted protein assembled in strict 1:1:1 ratio from three types of subunit chain (C1qA, C1qB and C1qC) and a single C1q molecule consists of 18 subunits [1] . The expression of C1QA, C1QB and C1QC mRNA in developing osteoclasts was examined. The monocyte precursors are known to lack significant C1q expression [15] . The three mRNA species were detected by day 3 and remained prominently detected for the rest of the culture period. PCR detection of C1Q mRNA on days 3, 9 and 21 is shown (Figure 2A ). C1Q mRNA expression in DCs and macrophages was similarly examined (Figure 2A) .
The expression of cathepsin K, an osteoclast signature molecule [30] was also examined. CTSK (cathepsin K) mRNA was low in fresh monocytes, but it was strongly induced during development into osteoclasts by day 9, which was maintained until day 21 ( Figure 2A ). In contrast, CTSK mRNA remained low in DCs. In the macrophage culture, CTSK mRNA showed a weak increase at both days 9 and 21. These results further stress the osteoclast nature of the cells and show that osteoclasts acquire increased C1Q mRNA expression like macrophages and DCs.
C1q protein is expressed and secreted by osteoclasts
To evaluate osteoclast production of C1q at the protein level, cells harvested during a 21-day culture period were subjected to Western blotting. The anti-C1q antibody detected a 26-27 kDa band equivalent in size to the C1qA and C1qB chains ( Figure 2B) . A faint band of approx 24 kDa, equivalent to C1qC in size,
Figure 1 Microscopic analysis of cultured osteoclasts and macrophages
Day 8 osteoclasts (A, C and E) and macrophages (B, D and F) were examined. First, cells were cultured on glass coverslips, fixed and stained for TRAP expression using the acid phosphatase/leucocytes kit (Sigma-Aldrich). Slides were air-dried and examined using an Olympus IX81 inverted microscope and ImagePro Plus software (A and B) . The permeabilized osteoclasts were, after washing, also stained with rhodamine-phalloidin (5 units/ml). Coverslips were mounted using Vectorshield mounting medium containing DAPI and cells were analysed using an Olympus BX-60 digital microscope and ImagePro Plus software (C and D). Macrophages and osteoclasts were also cultured on osteologic discs for 8 days. Cells were removed using bleach and water and resorption pits on the discs were visualized using an Olympus IX81 inverted microscope and ImagePro Plus software (E and F). Scale bars = 100 μm.
was also detectable in some samples. Fresh monocytes showed no detectable C1q protein expression as previously reported [15] . This is despite a low level of C1Q mRNA in these cells (Figure 2A ). C1q protein became detectable at day 3, peaked at day 6 and appeared largely sustained for the rest of the culture period. Compared with osteoclasts, macrophages produced a much higher level of C1q protein throughout the course of the culture, but the pattern was similar, i.e. detectable by day 3, peaked by day 6 and sustained throughout the rest of the culture period ( Figure 2B ).
In DCs, C1q protein expression was delayed compared with osteoclasts and macrophages; it was only detectable by day 6 ( Figure 2B ). The peak C1q expression in DCs was also delayed ( Figure 2B ).
Following the same culture scheme, secreted C1q was measured in the medium using a sandwich ELISA in which a goat antihuman C1q antibody (IgG) was immobilized to capture C1q and bound C1q was then detected using a mouse anti-C1q antibody. As shown in Figure 2(C) , in all three cell types, C1q secretion was undetectable at day 3, but it became detectable at day 6. C1q secretion was especially prominent in the macrophage culture. For the rest of the culture period, C1q levels continued to increase in the macrophage and DC cultures, suggesting continued C1q secretion by these cells. However, this increase was less obvious in the osteoclast culture, which suggests reduced C1q secretion with osteoclast progression to maturation ( Figure 2C ).
IFNγ induces C1q expression by osteoclasts
Macrophage production of C1q can be regulated by diverse stimuli, including microbial structures, cytokines, hormones and drugs, and IFNγ is one such stimulus [31] . IFNγ also induces C1Q gene expression in DCs [32] . Whether IFNγ regulates osteoclast production of C1q is unknown. In the present study,
Figure 2 C1q and cathepsin K expression by osteoclasts, macrophages and DCs
(A) RNA was isolated from cultured osteoclasts, macrophages and DCs at days 3, 9 and 21 for PCR assessment of C1QA , C1QB and C1QC and, as a control, CTSK mRNA expression (Cat K). PCR was also performed with monocyte RNA (Mo). The PCRs were examined on a 1.5 % agarose gel. (B) Cells cultured for 3, 6, 9, 12, 16 and 21 days were washed and lysed. The cell lysates (10 μg of protein) were separated on 12.5 % (w/v) gels under reducing conditions and C1q and, as a control, β-actin were detected on these blots using a goat anti-C1q or mouse anti-β-actin antibody. Monocyte lysates (day 0) were included as controls. After washing, blots were incubated with a rabbit anti-goat or goat anti-mouse IgG (alkaline phosphatase-conjugated) secondary antibody. Signals were developed using the Immuno-Star chemiluminescent substrate (Bio-Rad Laboratories). The molecular mass in kDa is indicated on the left-hand side. (C) Culture medium from osteoclast, macrophage and DC cultures were harvested at days 3, 6, 9, 12, 16 and 21 and examined for C1q secretion by ELISA. Results from triplicate ELISA experiments are presented as means + − S.D. and are representative of three independent experiments. OC, osteoclast; Mac, macrophage.
osteoclasts, macrophages and DCs were washed at day 8 and then stimulated with IFNγ for 48 h. At day 10, the C1q level was found to be markedly elevated in IFNγ -treated, as compared with untreated, osteoclast cultures ( Figure 3A) . Without IFNγ treatment, macrophages and DCs were able to secrete significant C1q, but this secretion was increased many fold with IFNγ stimulation ( Figure 3A) . LPS had limited effects on C1q secretion from all three cell types. Intracellular C1q expression was then determined at the singlecell level by flow cytometry. Cells were fixed and permeabilized, and intracellular C1q was then detected using a mouse antiC1q monoclonal antibody. As shown in Figure 3(B) , without IFNγ treatment day 8 osteoclasts expressed low intracellular C1q, whereas significant C1q was detected in macrophages and DCs. IFNγ treatment increased intracellular C1q expression in all three cell types and its effect was especially prominent on osteoclasts ( Figure 3B ). In this experiment, LPS again had limited effects ( Figure 3B ). These results consistently show C1q production and secretion by osteoclasts. The function of osteoclast-derived C1q and its drastic induction by IFNγ remain to be investigated.
C1q is preferentially produced by smaller osteoclasts
As well as flow cytometry, fluorescence microscopy was also used to examine intracellular C1q expression in the cultured osteoclasts. Without IFNγ stimulation, intracellular C1q was detected in a fraction of the cultured osteoclasts ( Figure 3C ). In cultured DCs and macrophages, C1q was also detected in a fraction of the cells (results not shown). In the osteoclast culture, intense C1q-producing cells were mostly small cells and C1q levels in giant osteoclasts were low or undetectable. After IFNγ treatment, the C1q signal was globally increased in small and large osteoclasts ( Figure 3C ). However, it remained that the C1q signal was much higher in the small osteoclasts as compared with giant osteoclasts. LPS treatment again had no detectable effects.
In the present study, early endosomes were also identified in osteoclasts by staining the early endosome antigen EEA-1. This was to ascertain whether the fluorescently detected intracellular C1q was de novo synthesized by the cultured osteoclasts as it could also have originated from the extracellular medium through endocytosis. C1q showed no co-localization with EEA-1 in osteoclasts ( Figure 3C ). By Pearson's correlation analysis, the coefficient r values for all three staining conditions were insignificant (results not shown). This suggests that the C1q molecules are synthesized by the osteoclasts.
Taken together, the results of the present study so far show that C1q is produced and secreted by cultured osteoclasts, especially the small osteoclasts which are likely to be less mature osteoclasts. This may explain why, after 8 days in culture, osteoclasts generally secreted less C1q than DCs and macrophages, although this was effectively restored upon IFNγ treatment ( Figure 3A) . The preferential C1q production by less mature osteoclasts suggests a potential role for C1q at the osteoclast development stage. for three independent experiments. Statistical analysis was performed by multiple unpaired t test (*P < 0.05, **P < 0.01). (B) To detect intracellular C1q by flow cytometry, cells were treated in six-well plates. After 48 h, cells were harvested, fixed, permeabilized and stained using a mouse anti-C1q monoclonal antibody. Solid trace, isotype IgG; blue trace, PBS control; orange trace, LPS treatment; red trace, IFNγ treatment. (C) To visualize subcellular localization of C1q in osteoclasts by fluorescence microscopy, cells were cultured on glass coverslips and were, after treatment with IFNγ (100 ng/ml), LPS (0.5 μg/ml) or, as a control, PBS for 48 h, fixed and permeabilized. After washing, cells were stained using primary mouse anti-C1q and rabbit anti-EEA1 antibodies followed by staining with secondary goat anti-rabbit IgG (Cy3-conjugated) and goat anti-mouse IgG (FITC-conjugated) antibodies. The nuclei are stained with DAPI. Scale bar = 25 μm.
C1q enhances osteoclast differentiation from monocytes
C1q has been shown to regulate DC development from monocytes. First, addition of sC1q (soluble C1q) to DC cultures yielded DCs that were refractory to maturation signals [33] . Secondly, DCs cultured on imC1q (immobilized C1q) acquired tolerogenic properties [34] . In the present study the ability of C1q to regulate osteoclast development was evaluated using sC1q and imC1q. As controls, sBSA (soluble BSA) and imBSA (immobilized BSA) were used. The cultured osteoclasts were evaluated on the basis of the expression of signature osteoclast molecules including ACP5 (TRAP), CTSK, CALCR (calcitonin receptor), CA2 (carbonic anhydrase II) and NFATC1.
sC1q had little effect on osteoclast expression of these signature molecules (Figure 4) . In contrast, osteoclasts cultured on imC1q (C1q-osteoclasts) systematically up-regulated the expression of these molecules by 2-7-fold (Figure 4) . Interestingly, C1q-osteoclasts also exhibited an approximately 2-fold upregulation of TNFRSF11A (RANK) and the MCSFR (M-CSF receptor) expression (Figure 4 ), which we think may render these cells more sensitive to RANKL and M-CSF, which were cytokines used for osteoclast generation in the present study. Osteoclasts also produced MCSF, but imC1q generally reduced its expression in osteoclasts, although the reduction was not statistically significant (Figure 4 ).
Osteoclasts also expressed the IL6, IL10 and TGFB1 cytokines, with C1q-treated osteoclasts producing much more IL6 and IL10 than osteoclasts cultured on imBSA (Figure 4 ). IL-6 is known to promote osteoclast differentiation from monocytes [35] . IL6 was not significantly induced by sC1q (Figure 4 ). The differences between sC1q and imC1q in promoting osteoclast development were striking, which could attribute to more effective C1q receptor cross-linking on monocytes by imC1q or exposure of conformation-dependent binding sites on imC1q.
C1q is produced by endogenous bone osteoclasts
C1q expression by endogenous bone osteoclasts was assessed by immunohistochemistry. Femoral bone samples were fixed and decalcified and 3-μm sections were then stained using a goat anti-C1q antibody and counterstained with haematoxylin. Analysis of C1q expression in these human bone tissue specimens revealed intense C1q immunopositivity in mononuclear cells adapted to bone tissue, which were consistent with immature osteoclasts ( Figure 5 ) (results not shown). The presence of C1q was also evident in multinucleated giant osteoclasts ( Figure 5 ). These results are largely consistent with the results obtained with cultured osteoclasts. The apparently weak C1q signals in cultured multinucleated osteoclasts may reflect the
Figure 4 C1q induction of characteristic osteoclast gene expression in osteoclasts
Monocytes were cultured for 8 days in the presence of: imC1q, imBSA, sC1q (50 μg/ml) or sBSA (50 μg/ml). Where imC1q or imBSA was used, these plates were coated with the proteins (50 μg/ml in PBS) overnight at 4 • C. RNA was isolated from these cells and mRNA for the specified molecules were detected by PCR in triplicate reactions. The RQ value for each test RNA sample was obtained and results are presented as means + − S.E.M. for three independent experiments. Statistical analysis was performed by one-way ANOVA and Bonferroni's post-test (**P < 0.01, ***P < 0.001).
imperfect in vitro microenvironments in which osteoclasts were cultured. However, these non-quantitative immunohistochemical data remained largely in line with immature osteoclasts expressing more C1q than mature osteoclasts, as deduced from the cultured osteoclasts.
DISCUSSION
Tissue macrophages originate from blood monocytes but, in different organs, these macrophages display very different phenotypes and functions [18, 20] . C1q is produced by cultured macrophages [14] [15] [16] [17] , but it remains to be determined whether C1q is produced by organ-specific endogenous macrophages. C1q deficiency causes SLE, a multi-organ autoimmune disease [36] [37] [38] . Knowledge of whether C1q is produced by some or all organ-specific macrophages helps in understanding systemic SLE pathogenesis and its local manifestations. Following a method initially described by Quinn et al. [39] , we cultured osteoclasts from blood monocytes using M-CSF and RANKL. These cultured cells exhibited characteristic osteoclast phenotype and bone-resorbing capacity, and C1q expression by these cultured osteoclasts was clearly demonstrated. Furthermore, we also validated C1q expression in endogenous bone osteoclasts by immunohistochemistry. This is the first report of C1q production by osteoclasts. Intracellular C1q was detected by flow cytometry and fluorescence microscopy, and secreted C1q was detected by ELISA. In a number of experiments, osteoclast production of C1q has been compared with macrophages and DCs.
Another phenomenon regarding C1q production by osteoclasts is its sensitive induction by IFNγ . Although the physiological relevance remains undefined, the magnitude of IFNγ induction for a protein that is normally found in the plasma at >60 μg/ml, is impressively large (Figure 3 ). How this may affect the overall plasma C1q level during local bone infection or inflammation, when IFNγ production is likely to surge, is unclear, but it could have significant effects on local bone tissues, e.g. the joints.
One of the C1q effects in the bone could be manifested through regulating osteoclast development. As suggested by our data, solid-phase C1q was potent in globally increasing the expression of signature osteoclast molecules, including TRAP, cathepsin K, calcitonin receptor, carbonic anhydrase II and the transcription factor NFATc1. This implies that osteoclast development could be impeded in patients with SLE as a result of genetic C1q deficiency or acquired C1q deficiency owing to consumption or impaired production.
The cultured osteoclasts consist of multinucleated giant cells corresponding to mature osteoclasts and mononuclear cells which are likely to be less mature osteoclasts. In vivo, both forms of osteoclasts have been found ( Figure 5 ). By fluorescence microscopy, C1q was mainly detected in the mononuclear fraction of cultured osteoclasts. However, after treatment with IFNγ , C1q became detectable in multinucleated osteoclasts as well. This implies an indirect, yet potent, osteoclastogenic role for IFNγ through C1q induction in osteoclasts. The physiological context where IFNγ , which is produced by activated T-cells and NK (natural killer) cells, regulates osteoclasts is undefined. However, it is likely to occur in tissue inflammation such as arthritis. Activated T-cells also express the other major osteoclastogenic factor RANKL [40, 41] . Therefore, in inflamed bone tissues, activated T-cells could promote osteoclastogenesis through multiple mechanisms, including the expression of RANKL-and IFNγ -induced C1q production. These could contribute to the usual bone erosion found in inflammatory arthritis in C1q-sufficient patients.
SLE is known for its heterogeneous organ-specific manifestations. In the bone, it is presented as inflammatory arthritis, but this type of arthritis lacks the severe bone erosion found in rheumatoid and psoriatic arthritis [42] . There is no previous account of complement contribution to the non-erosive nature of this lupus arthritis, known as Jaccoud's arthritis, but our results in the present study suggest a connection with complement C1q.
Genetic C1q deficiency causes SLE, but this is rare. However, acquired C1q deficiency at the protein level occurs in active SLE disease [43, 44] . C1q can be consumed due to a surge in immune complexes or anti-C1q autoantibodies [45, 46] . Paediatric SLE patients do suffer from drug-induced bone erosion, but this is not due to increased osteoclastogenesis [47] . In contrast, these paediatric patients showed reduced osteoclast development and osteoclast functions [47] . Reduced plasma C1q was found to be positively associated with the severity of paediatric SLE [48] .
In comparison with the less-defined contributions of C1q deficiency (genetic or functional) with the non-erosive nature of SLE arthritis, type I IFN (IFNα/β) appears to inhibit osteoclastogenesis [49] . A recent study stated that the increased type I IFN production found in patients with SLE divert the common osteoclast/DC precursors to differentiate preferentially to DCs at the expenses of osteoclastogenesis [50] . Osteoclastderived C1q could interplay with type I IFN to influence osteoclast development. For example, on imC1q, osteoclasts could be more resistant to IFNα/β inhibition. Conversely, IFNα/β could inhibit osteoclastogenesis by suppressing immature osteoclast production of C1q. In the bone, osteoclast-derived C1q could inhibit IFNα production by plasmacytoid DCs, the main producers of IFNα. Further experimental work is needed to test these possibilities.
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